Jackson Square Partners, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jackson Square Partners, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2020$205,825,000
+14.9%
2,298,190
+27.8%
1.03%
-8.7%
Q1 2020$179,163,000
-12.3%
1,797,743
+1.1%
1.13%
+5.5%
Q4 2019$204,403,000
-5.6%
1,778,966
+3.6%
1.07%
-9.9%
Q3 2019$216,563,000
-8.0%
1,716,851
-12.2%
1.19%
-2.4%
Q2 2019$235,339,000
+62.5%
1,955,625
+18.1%
1.22%
+53.7%
Q1 2019$144,838,000
-1.4%
1,655,676
+12.8%
0.79%
-12.0%
Q4 2018$146,845,000
-10.9%
1,467,726
+2.0%
0.90%
+8.2%
Q3 2018$164,899,000
+47.7%
1,439,167
+15.6%
0.83%
+46.1%
Q2 2018$111,662,0001,245,1220.57%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders